These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7835210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
    Yamanouchi T, Akanuma Y.
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB.
    Diabetes Technol Ther; 2003 Oct; 5(3):355-63. PubMed ID: 12828817
    [Abstract] [Full Text] [Related]

  • 6. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
    Stickle D, Turk J.
    Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
    [Abstract] [Full Text] [Related]

  • 7. Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province.
    Chen C, Wang X, Tan Y, Yang J, Yuan Y, Chen J, Guo H, Wang B, Sun Z, Wang Y.
    J Diabetes; 2020 Jun; 12(6):447-454. PubMed ID: 31846192
    [Abstract] [Full Text] [Related]

  • 8. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y, Yuan Y, Zhang Y, Lei C, Zhou Y, He J, Sun Z.
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [Abstract] [Full Text] [Related]

  • 9. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
    Yamanouchi T, Minoda S, Yabuuchi M, Akanuma Y, Akanuma H, Miyashita H, Akaoka I.
    Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
    [Abstract] [Full Text] [Related]

  • 10. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y, Yang R, Song Y, Wang Y.
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [Abstract] [Full Text] [Related]

  • 11. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
    Namba N, Watanabe F, Tokuda M, Mino M, Furuya E.
    Diabetes Res Clin Pract; 1994 May; 24(1):55-61. PubMed ID: 7924887
    [Abstract] [Full Text] [Related]

  • 12. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H, Ma X, Yin J, Wang Y, He X, Bao Y, Zhou J, Jia W.
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [Abstract] [Full Text] [Related]

  • 13. Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application.
    Phillipou G, James SK, Frith RG, Farrant RK, Phillips PJ.
    Clin Chem; 1994 Jul; 40(7 Pt 1):1322-6. PubMed ID: 8013107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group.
    Robertson DA, Alberti KG, Dowse GK, Zimmet P, Tuomilehto J, Gareeboo H.
    Diabet Med; 1993 Jul; 10(1):56-60. PubMed ID: 8435989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
    Yamanouchi T, Akaoka I, Akanuma Y, Akanuma H, Miyashita E.
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E423-7. PubMed ID: 2138419
    [Abstract] [Full Text] [Related]

  • 19. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry.
    Niwa T, Dewald L, Sone J, Miyazaki T, Kajita M.
    Clin Chem; 1994 Feb; 40(2):260-4. PubMed ID: 8313603
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of plasma 1,5-anhydroglucitol analysis in the diagnosis of diabetes mellitus].
    Yamanouchi T, Akaoka I.
    Nihon Rinsho; 1990 Dec; 48 Suppl():374-80. PubMed ID: 2086911
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.